(Q34648663)

3 August 2017

title

Serial infusions of low-dose ketamine for major depression (English)

1 reference

3 August 2017

11

Mark A Frye

1 reference

3 August 2017

Keith G Rasmussen

1

1 reference

3 August 2017

Timothy W Lineberry

2

1 reference

3 August 2017

Christine W Galardy

3

1 reference

3 August 2017

Simon Kung

4

1 reference

3 August 2017

Maria I Lapid

5

1 reference

3 August 2017

Brian A Palmer

6

1 reference

3 August 2017

Matthew J Ritter

7

1 reference

3 August 2017

Kathryn M Schak

8

1 reference

3 August 2017

Christopher L Sola

9

1 reference

3 August 2017

Allison J Hanson

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

20 February 2013

1 reference

Journal of Psychopharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

444-450

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Assessment of suicidal intention: The Scale for Suicide Ideation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A psychometric investigation of the Suicide Status Form II with a psychiatric inpatient sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Ketamine followed by memantine for the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

The use of a series of ketamine infusions in two patients with treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Ketamine-induced vesicopathy: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A case of sustained remission following an acute course of ketamine in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Antidepressant effect of ketamine during ECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Intravenous ketamine "burst" for refractory depression in a patient with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113478283

21 January 2018

Identifiers

DOI

10.1177/0269881113478283

1 reference

3 August 2017

1 reference